DROPSHOT THERAPEUTICS Trademark

Trademark Overview


On Thursday, August 8, 2024, a trademark application was filed for DROPSHOT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DROPSHOT THERAPEUTICS trademark a serial number of 98688672. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, August 21, 2025. This trademark is owned by Dropshot Therapeutics LLC. The DROPSHOT THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Laboratory and scientific apparatus and instruments in the nature of spectrophotometers, fluorometric quantifiers, capillary electrophoresis systems, gel electrophoresis systems, fragment analyzers, thermocyclers, Polymerase Chain Reaction (PCR) machines, real-time quantitative Polymerase Chain Reaction (qPCR) instruments, reverse transcription qpcr instruments, digital pcr systems, isothermal amplification devices, electroporators, nucleofectors, microinjection systems with micromanipulators, transfection instruments, transfection kits, microfluidic transfection systems, microfluidic droplet systems, next-generation sequencers, all used for storing nucleic acid molecules, and for amplification, assembly, and modification of genetic fragments, genotyping, gene modification and analysis of cells, samples and biological systems

Therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Therapeutic agents, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of different heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations, therapeutic agents, and therapeutic agent preparations for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical and biological preparations based on nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations for the treatme...

Genome editing reagents for research purposes; Biochemicals and biologics, namely, engineered proteins in raw material form for scientific and pharmaceutical research in the fields of gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction; Engineered proteins in raw material form for use in scientific research and analysis in the fields of genetic diseases, gene therapy, gene modification and cell therapy; chemical reagents, reagents, enzymes, as well as kits primarily comprised of enzymes and nucleotide monomers and also containing solid phase synthesis media and synthesis plates for laboratory use, all for use in scientific research specific to synthesizing polynucleotides, and more specifically for research related to amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells

Medical services for organ perfusion, namely, gene modification; Medical services for organ perfusion via a procedure; Medical and health services in the fields of DNA analysis and testing, genetics and genetic testing; Medical diagnostic services for testing DNA, RNA, and protein samples for diseased cells; Genetic testing and diagnostic reporting for medical purposes; providing a website featuring medical information regarding genetics; Genetic medical analysis and diagnostic reporting services for medical purposes; Medical evaluation of gene modification, organ transplants, organ perfusion, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness for patients

Medical devices and apparatus for the delivery of therapeutic agents; Medical devices and apparatus for the delivery of therapeutic agents to the heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system; Medical apparatus, namely, blood pumping system for use in organ perfusion; Medical apparatus for use in organ perfusion, namely, roller pumps, centrifugal pumps, membrane oxygenators, heat exchangers, reservoirs, cannulas, extracorporeal membrane oxygenation circuits, tubing, cannulas, aortic root cannulas, antegrade cardioplegia cannulas, retrograde cardioplegia cannulas, cardioplegia accessories, normothermic machines, hypothermic machines, multi-temperature machine perfusion systems, ultrasound-assisted infusion catheters, ultrasonic cores, and consoles for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Organ and tissue perfusion media, namely, fluids to preserve human organs; Medical apparatus for perfu...

Scientific research and development of therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; scientific research in the field of gene editing technology; Scientific research and development, namely, gene modification, as well as gene regulation and gene editing, for researching and developing modified human tissue cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; medical and scientific research in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, genetic diseases, gene therapy and cell therapy; providing medical research information and scientific research information in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, ge...
dropshot therapeutics

General Information


Serial Number98688672
Word MarkDROPSHOT THERAPEUTICS
Filing DateThursday, August 8, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, August 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLaboratory and scientific apparatus and instruments in the nature of spectrophotometers, fluorometric quantifiers, capillary electrophoresis systems, gel electrophoresis systems, fragment analyzers, thermocyclers, Polymerase Chain Reaction (PCR) machines, real-time quantitative Polymerase Chain Reaction (qPCR) instruments, reverse transcription qpcr instruments, digital pcr systems, isothermal amplification devices, electroporators, nucleofectors, microinjection systems with micromanipulators, transfection instruments, transfection kits, microfluidic transfection systems, microfluidic droplet systems, next-generation sequencers, all used for storing nucleic acid molecules, and for amplification, assembly, and modification of genetic fragments, genotyping, gene modification and analysis of cells, samples and biological systems
Goods and ServicesTherapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Therapeutic agents, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of different heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations, therapeutic agents, and therapeutic agent preparations for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical and biological preparations based on nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations containing genetically modified cells for use in the treatment of genetic diseases and disorders; pharmaceutical preparations for detecting genetic predispositions for medical purposes; Gene therapy, gene editing, genome editing, and targeted gene replacement and insertion products, namely, for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; cell therapies in the nature of treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; gene therapy products in the nature of genetically engineered tissues for the treatment of genetic diseases and disorders
Goods and ServicesGenome editing reagents for research purposes; Biochemicals and biologics, namely, engineered proteins in raw material form for scientific and pharmaceutical research in the fields of gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction; Engineered proteins in raw material form for use in scientific research and analysis in the fields of genetic diseases, gene therapy, gene modification and cell therapy; chemical reagents, reagents, enzymes, as well as kits primarily comprised of enzymes and nucleotide monomers and also containing solid phase synthesis media and synthesis plates for laboratory use, all for use in scientific research specific to synthesizing polynucleotides, and more specifically for research related to amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells
Goods and ServicesMedical services for organ perfusion, namely, gene modification; Medical services for organ perfusion via a procedure; Medical and health services in the fields of DNA analysis and testing, genetics and genetic testing; Medical diagnostic services for testing DNA, RNA, and protein samples for diseased cells; Genetic testing and diagnostic reporting for medical purposes; providing a website featuring medical information regarding genetics; Genetic medical analysis and diagnostic reporting services for medical purposes; Medical evaluation of gene modification, organ transplants, organ perfusion, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness for patients
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical devices and apparatus for the delivery of therapeutic agents; Medical devices and apparatus for the delivery of therapeutic agents to the heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system; Medical apparatus, namely, blood pumping system for use in organ perfusion; Medical apparatus for use in organ perfusion, namely, roller pumps, centrifugal pumps, membrane oxygenators, heat exchangers, reservoirs, cannulas, extracorporeal membrane oxygenation circuits, tubing, cannulas, aortic root cannulas, antegrade cardioplegia cannulas, retrograde cardioplegia cannulas, cardioplegia accessories, normothermic machines, hypothermic machines, multi-temperature machine perfusion systems, ultrasound-assisted infusion catheters, ultrasonic cores, and consoles for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Organ and tissue perfusion media, namely, fluids to preserve human organs; Medical apparatus for perfusing organs inside or outside human bodies, namely, system for use in artificial organ support; Medical apparatus for use in organ perfusion, namely for gene modification; Testing instruments for medical diagnostic purposes, namely, medical diagnostic apparatus for analyzing the genetic characteristics of body fluids, tissue samples and liquid biopsies for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; medical apparatus for gene modification, namely, in vitro diagnostic labeled quantitative polymerase chain reaction and digital polymerase chain reaction analyzers with disease-specific test kits, in vitro diagnostic next-generation sequencing analyzers with companion diagnostic panels, microarray scanning instruments, benchtop sequencing machines for confirmatory diagnostic applications, automated nucleic acid extraction systems with in vitro diagnostic reagent cartridges, fluorescence in situ hybridization imaging systems with automated probe scoring capabilities, and point-of-care molecular diagnostic analyzers using closed cartridge formats for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases
Goods and ServicesScientific research and development of therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; scientific research in the field of gene editing technology; Scientific research and development, namely, gene modification, as well as gene regulation and gene editing, for researching and developing modified human tissue cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; medical and scientific research in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, genetic diseases, gene therapy and cell therapy; providing medical research information and scientific research information in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services on the subject of targeting genetic therapies to specific individuals; medical and scientific research on treatment of genetic diseases and disorders

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDropshot Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPortsmouth, NH 03801

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024NEW APPLICATION ENTERED
Sunday, February 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 24, 2025ASSIGNED TO EXAMINER
Monday, February 24, 2025NON-FINAL ACTION WRITTEN
Friday, May 16, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 16, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 24, 2025NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED